These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 8033208)
1. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Krek W; Ewen ME; Shirodkar S; Arany Z; Kaelin WG; Livingston DM Cell; 1994 Jul; 78(1):161-72. PubMed ID: 8033208 [TBL] [Abstract][Full Text] [Related]
2. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells. Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533 [TBL] [Abstract][Full Text] [Related]
3. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Yang R; Müller C; Huynh V; Fung YK; Yee AS; Koeffler HP Mol Cell Biol; 1999 Mar; 19(3):2400-7. PubMed ID: 10022926 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the cyclin E gene by transcription factor E2F1. Ohtani K; DeGregori J; Nevins JR Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12146-50. PubMed ID: 8618861 [TBL] [Abstract][Full Text] [Related]
5. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites. Li JM; Hu PP; Shen X; Yu Y; Wang XF Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170 [TBL] [Abstract][Full Text] [Related]
6. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Lees E; Faha B; Dulic V; Reed SI; Harlow E Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067 [TBL] [Abstract][Full Text] [Related]
7. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Shirodkar S; Ewen M; DeCaprio JA; Morgan J; Livingston DM; Chittenden T Cell; 1992 Jan; 68(1):157-66. PubMed ID: 1531040 [TBL] [Abstract][Full Text] [Related]
8. Deregulation of specific E2F complexes by the v-mos oncogene. Afshari CA; Rhodes N; Paules RS; Mudryj M Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. Hofmann F; Livingston DM Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Iwanaga R; Ohtani K; Hayashi T; Nakamura M Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190 [TBL] [Abstract][Full Text] [Related]
11. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707 [TBL] [Abstract][Full Text] [Related]
12. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Cobrinik D; Whyte P; Peeper DS; Jacks T; Weinberg RA Genes Dev; 1993 Dec; 7(12A):2392-404. PubMed ID: 8253385 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of E2F-1 by cyclin A-cdk2. Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523 [TBL] [Abstract][Full Text] [Related]
14. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Kiess M; Gill RM; Hamel PA Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306 [TBL] [Abstract][Full Text] [Related]
15. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Johnson DG; Ohtani K; Nevins JR Genes Dev; 1994 Jul; 8(13):1514-25. PubMed ID: 7958836 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts. Kim TA; Ravitz MJ; Wenner CE J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069 [TBL] [Abstract][Full Text] [Related]
19. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Sellers WR; Rodgers JW; Kaelin WG Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800 [TBL] [Abstract][Full Text] [Related]
20. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Devoto SH; Mudryj M; Pines J; Hunter T; Nevins JR Cell; 1992 Jan; 68(1):167-76. PubMed ID: 1310073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]